# Ropivacaine Plus Magnesium Sulphate Infiltration

> **NCT05294393** · PHASE4 · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 68 (actual)

## Conditions studied

- Thyroid Diseases
- Parathyroid Diseases
- Postoperative Pain
- Anesthesia, Local

## Interventions

- **DRUG:** Placebo Comparator: N/S 0.9%
- **DRUG:** Ropivacaine 10%
- **DRUG:** Ropivacaine 10% plus magnesium sulphate 10mg/kg

## Key facts

- **NCT ID:** NCT05294393
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-19
- **Primary completion:** 2024-01-18
- **Final completion:** 2024-01-18
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05294393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05294393, "Ropivacaine Plus Magnesium Sulphate Infiltration". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05294393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*